Literature DB >> 20138938

Silk fibroin encapsulated powder reservoirs for sustained release of adenosine.

Eleanor M Pritchard1, Cory Szybala, Detlev Boison, David L Kaplan.   

Abstract

Due to its unique properties, silk fibroin was studied as a biodegradable polymer vehicle for sustained, local delivery of the anticonvulsant adenosine from encapsulated reservoirs. Silk is a biologically derived protein polymer that is biocompatible, mechanically strong and degrades to non-toxic products in vivo. To achieve local, sustained, controlled adenosine release from fully degradable implants, solid adenosine powder reservoirs were coated with silk fibroin. Material properties of the silk coating including thickness, crystallinity and morphology were investigated to assess the relationships between silk coating biomaterial features and adenosine release from silk encapsulated reservoirs. Reservoir coating thickness was varied through manipulation of the silk coating solution concentration and number of coatings applied. Release studies were also performed in proteinase type XIV to model the effects of degradation. Increasing the barrier to diffusion, either by increasing coating thickness or crystallinity was found to delay adenosine burst, decrease average daily release rate, and increase duration of release. In the case of encapsulated reservoirs coated with eight layers of 8% (w/v) silk, a linear release profile was observed and adenosine release was sustained for 14days. The ability to achieve nearly constant release for 2weeks for adenosine via control of the silk coating suggests these encapsulated reservoirs represent a novel system for delivering adenosine. We anticipate that this approach could also be extended to other implant needs and small-molecule drugs to treat a range of clinical needs. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138938      PMCID: PMC2868941          DOI: 10.1016/j.jconrel.2010.01.035

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  43 in total

Review 1.  Adenosine and suppression of seizures.

Authors:  T V Dunwiddie
Journal:  Adv Neurol       Date:  1999

Review 2.  Formulation and delivery issues for monoclonal antibody therapeutics.

Authors:  Ann L Daugherty; Randall J Mrsny
Journal:  Adv Drug Deliv Rev       Date:  2006-05-22       Impact factor: 15.470

Review 3.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

Review 4.  Therapeutic applications of implantable drug delivery systems.

Authors:  A K Dash; G C Cudworth
Journal:  J Pharmacol Toxicol Methods       Date:  1998-07       Impact factor: 1.950

5.  Dissolution and compatibility considerations for the use of mannitol in solid dosage forms.

Authors:  D R Ward; L B Lathrop; M J Lynch
Journal:  J Pharm Sci       Date:  1969-12       Impact factor: 3.534

Review 6.  Silk-based biomaterials.

Authors:  Gregory H Altman; Frank Diaz; Caroline Jakuba; Tara Calabro; Rebecca L Horan; Jingsong Chen; Helen Lu; John Richmond; David L Kaplan
Journal:  Biomaterials       Date:  2003-02       Impact factor: 12.479

7.  Potential applications of PLGA film-implants in modulating in vitro drugs release.

Authors:  María Jesús Dorta; Ana Santoveña; Matías Llabrés; José B Fariña
Journal:  Int J Pharm       Date:  2002-11-06       Impact factor: 5.875

8.  Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.

Authors:  Maciej S Lesniak; Urvashi Upadhyay; Rory Goodwin; Betty Tyler; Henry Brem
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

Review 9.  Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.

Authors:  Detlev Boison
Journal:  Neurodegener Dis       Date:  2007       Impact factor: 2.977

Review 10.  New methods for direct delivery of chemotherapy for treating brain tumors.

Authors:  Andrew J Sawyer; Joseph M Piepmeier; W Mark Saltzman
Journal:  Yale J Biol Med       Date:  2006-12
View more
  30 in total

1.  Stabilization of vaccines and antibiotics in silk and eliminating the cold chain.

Authors:  Jeney Zhang; Eleanor Pritchard; Xiao Hu; Thomas Valentin; Bruce Panilaitis; Fiorenzo G Omenetto; David L Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

Review 2.  Silk-based delivery systems of bioactive molecules.

Authors:  Keiji Numata; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2010-03-16       Impact factor: 15.470

3.  Materials fabrication from Bombyx mori silk fibroin.

Authors:  Danielle N Rockwood; Rucsanda C Preda; Tuna Yücel; Xiaoqin Wang; Michael L Lovett; David L Kaplan
Journal:  Nat Protoc       Date:  2011-09-22       Impact factor: 13.491

4.  Process Analytical Quality Control of Tailored Drug Release Formulation Prepared via Hot-Melt Extrusion Technology.

Authors:  Jun-Bom Park; Beom-Jin Lee; Chin-Yang Kang; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2017-01-25       Impact factor: 3.981

Review 5.  Extended release formulations using silk proteins for controlled delivery of therapeutics.

Authors:  Burcin Yavuz; Laura Chambre; David L Kaplan
Journal:  Expert Opin Drug Deliv       Date:  2019-07-01       Impact factor: 6.648

6.  Silk Protein Bioresorbable, Drug-Eluting Ear Tubes: Proof-of-Concept.

Authors:  Sarah A Bradner; Deepa Galaiya; Nikhila Raol; David L Kaplan; Chistopher J Hartnick
Journal:  Adv Healthc Mater       Date:  2019-01-09       Impact factor: 9.933

7.  Transdermal delivery devices: fabrication, mechanics and drug release from silk.

Authors:  Waseem K Raja; Scott Maccorkle; Izzuddin M Diwan; Abdurrahman Abdurrob; Jessica Lu; Fiorenzo G Omenetto; David L Kaplan
Journal:  Small       Date:  2013-05-08       Impact factor: 13.281

8.  Film interface for drug testing for delivery to cells in culture and in the brain.

Authors:  Min D Tang-Schomer; David L Kaplan; Michael J Whalen
Journal:  Acta Biomater       Date:  2019-03-02       Impact factor: 8.947

9.  Disseminated injection of vincristine-loaded silk gel improves the suppression of neuroblastoma tumor growth.

Authors:  Jasmine Zeki; Jordan S Taylor; Burcin Yavuz; Jeannine Coburn; Naohiko Ikegaki; David L Kaplan; Bill Chiu
Journal:  Surgery       Date:  2018-07-27       Impact factor: 3.982

10.  Protein-protein nanoimprinting of silk fibroin films.

Authors:  Mark A Brenckle; Hu Tao; Sunghwan Kim; Mark Paquette; David L Kaplan; Fiorenzo G Omenetto
Journal:  Adv Mater       Date:  2013-03-11       Impact factor: 30.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.